These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37101017)

  • 1. Natural History of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay: a 4-Year Longitudinal Study.
    Lessard I; Côté I; St-Gelais R; Hébert LJ; Brais B; Mathieu J; Rodrigue X; Gagnon C
    Cerebellum; 2024 Apr; 23(2):489-501. PubMed ID: 37101017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From motor performance to participation: a quantitative descriptive study in adults with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Gagnon C; Brais B; Lessard I; Lavoie C; Côté I; Mathieu J
    Orphanet J Rare Dis; 2018 Sep; 13(1):165. PubMed ID: 30231904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional mobility in walking adult population with ataxia of Charlevoix-Saguenay.
    Lessard I; St-Gelais R; Hébert LJ; Côté I; Mathieu J; Brais B; Gagnon C
    Orphanet J Rare Dis; 2021 Oct; 16(1):432. PubMed ID: 34649570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation and Functional Independence in Adults With Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Muslemani S; Lessard I; Lavoie C; Côté I; Brais B; Mathieu J; Gagnon C
    Can J Occup Ther; 2022 Sep; 89(3):315-325. PubMed ID: 35469466
    [No Abstract]   [Full Text] [Related]  

  • 5. Documenting manifestations and impacts of autosomal recessive spastic ataxia of Charlevoix-Saguenay to develop patient-reported outcome.
    Tremblay M; Girard-Côté L; Brais B; Gagnon C
    Orphanet J Rare Dis; 2022 Oct; 17(1):369. PubMed ID: 36183078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploratory natural history of ataxia of Charlevoix-Saguenay: A 2-year follow-up.
    Gagnon C; Lessard I; Lavoie C; Côté I; St-Gelais R; Mathieu J; Brais B
    Neurology; 2018 Oct; 91(14):e1307-e1311. PubMed ID: 30158165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rehabilitation program to increase balance and mobility in ataxia of Charlevoix-Saguenay: An exploratory study.
    Lessard I; Masterman V; Côté I; Gagnon C; Duchesne E
    PLoS One; 2022; 17(12):e0279406. PubMed ID: 36576926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Molecular Findings of Autosomal Recessive Spastic Ataxia of Charlevoix Saguenay: an Iranian Case Series Expanding the Genetic and Neuroimaging Spectra.
    Ashrafi MR; Mohammadi P; Tavasoli AR; Heidari M; Hosseinpour S; Rasulinejad M; Rohani M; Akbari MG; Malamiri RA; Badv RS; Fathi D; Dehnavi AZ; Savad S; Rabbani A; Synofzik M; Mahdieh N; Rezaei Z
    Cerebellum; 2023 Aug; 22(4):640-650. PubMed ID: 35731353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spastic ataxias.
    Bereznyakova O; Dupré N
    Handb Clin Neurol; 2018; 155():191-203. PubMed ID: 29891058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of early-onset autosomal recessive spastic ataxia of Charlevoix-Saguenay diagnosed in adulthood.
    Sahin T; Karaarslan FT; Yilmaz R; Tekgül Ş; Başak AN; Akbostanci MC
    Clin Neurol Neurosurg; 2021 Feb; 201():106423. PubMed ID: 33348119
    [No Abstract]   [Full Text] [Related]  

  • 11. Wheelchair mobility, motor performance and participation of adult wheelchair users with ARSACS: a cross-sectional study.
    Bourassa J; Routhier F; Gagnon C; Rahn C; Hébert LJ; St-Gelais R; Rodrigue X; Brais B; Best KL
    Disabil Rehabil Assist Technol; 2023 May; 18(4):378-386. PubMed ID: 33307884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography in autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Parkinson MH; Bartmann AP; Clayton LMS; Nethisinghe S; Pfundt R; Chapple JP; Reilly MM; Manji H; Wood NJ; Bremner F; Giunti P
    Brain; 2018 Apr; 141(4):989-999. PubMed ID: 29538656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a Better Understanding of Walking Speed in Ataxia of Charlevoix-Saguenay: a Factor Exploratory Study.
    Lessard I; Hébert LJ; St-Gelais R; Côté I; Mathieu J; Brais B; Gagnon C
    Cerebellum; 2024 Aug; 23(4):1377-1385. PubMed ID: 38133849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel SACS p.Pro4154GlnfsTer20 mutation in a family with autosomal recessive spastic ataxia of Charlevoix-Saguenay.
    Samanci B; Gokalp EE; Bilgic B; Gurvit H; Artan S; Hanagasi HA
    Neurol Sci; 2021 Jul; 42(7):2969-2973. PubMed ID: 33559790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) - A Polish family with novel SACS mutations.
    Krygier M; Konkel A; Schinwelski M; Rydzanicz M; Walczak A; Sildatke-Bauer M; Płoski R; Sławek J
    Neurol Neurochir Pol; 2017; 51(6):481-485. PubMed ID: 28843771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Documenting the psychometric properties of the scale for the assessment and rating of ataxia to advance trial readiness of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Bourcier D; Bélanger M; Côté I; Brais B; Synofzik M; Brisson JD; Rodrigue X; Gagnon MM; Mathieu J; Gagnon C
    J Neurol Sci; 2020 Oct; 417():117050. PubMed ID: 32736199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and Reliability of Outcome Measures Assessing Dexterity, Coordination, and Upper Limb Strength in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
    Gagnon C; Lessard I; Brais B; Côté I; Lavoie C; Synofzik M; Mathieu J
    Arch Phys Med Rehabil; 2018 Sep; 99(9):1747-1754. PubMed ID: 29462597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Architecture in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): Insights into Disease Pathogenesis and Biomarkers.
    Rezende Filho FM; Bremner F; Pedroso JL; de Andrade JBC; Marianelli BF; Lourenço CM; Marques-Júnior W; França MC; Kok F; Sallum JMF; Parkinson MH; Barsottini OG; Giunti P
    Mov Disord; 2021 Sep; 36(9):2027-2035. PubMed ID: 33893680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a disease severity index for ataxia of Charlevoix-Saguenay.
    Gagnon C; Brais B; Lessard I; Lavoie C; Côté I; Mathieu J
    Neurology; 2019 Oct; 93(16):e1543-e1549. PubMed ID: 31534027
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.